Kimberly Sheehan
Responsable des Ressources Humaines chez MILESTONE PHARMACEUTICALS INC.
Provenance du réseau au premier degré de Kimberly Sheehan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kimberly Sheehan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Treasurer | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Wisconsin | College/University | Undergraduate Degree Graduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GENMARK DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member | |
| Optivara, Inc. | Chief Executive Officer | ||
| CRISPR THERAPEUTICS AG | Biotechnology | Director of Finance/CFO | |
| Northwestern Memorial Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Giles & Associates Consultancy
 Giles & Associates Consultancy Miscellaneous Commercial ServicesCommercial Services Giles & Associates Consultancy provides management consulting services for the healthcare industry. The private company is based in Lake Bluff, IL. The company was founded by Lisa M. Giles. Lisa M. Giles has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG Packaged SoftwareTechnology Services Cimeio Therapeutics AG is an applied gene editing and immunotherapy company based in Basel, Switzerland. Cimeio is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip) that have the potential to transform hematopoietic stem cell transplant. The Swiss company's technology platform is based on the design and expression of modified variants of naturally occurring cell surface proteins in hscs. These novel variants maintain their function but are resistant to depletion when targeted by a paired immunotherapy which has high affinity for the wild-type version of these proteins. Cimeio is the leader of the field of epitope editing and is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip), novel immunotherapies which have the potential to transform treatment of hematologic diseases. The company develops state-of-the-art immunotherapies, along with paired, modified variants of naturally occurring cell surface proteins in hscs. These immunotherapies have significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with hematologic malignancies, autoimmune disorders, and genetic diseases. The company was founded by Lukas Jeker and the CEO is Thomas Fuchs. | Packaged Software | Director/Board Member | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| G.D. Searle LLC | Corporate Officer/Principal | ||
| Juniata College | College/University | Undergraduate Degree | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Part of The Ensign Group, Inc., The Lexington operates a 125-bed assisted living facility. The company is based in Ventura, CA. | Medical/Nursing Services | Director of Finance/CFO | |
| ABIOMED, INC. | Medical Specialties | Director of Finance/CFO | |
| Art Institute of Chicago | College/University | Director/Board Member | |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services General Electric Healthcare Technologies, Inc. provides transformational medical technologies and services. The company is headquartered in Houston, TX. | Medical/Nursing Services | Corporate Officer/Principal | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Haptocure Ltd. | Director/Board Member | ||
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Association of Black Cardiologists
 Association of Black Cardiologists Miscellaneous Commercial ServicesCommercial Services The Association of Black Cardiologists (ABC) was founded in 1974 by Richard Allen Williams and 17 other medical professionals. The organization is based in New York, NY. The organization aims to save the hearts and minds of a diverse America. ABC provides access to clinical studies for investigators from multiple specialties through its clinical research network (ABC CRN). Recently, ABC has been involved in COVID-19 webinars and anti-racism training. | Miscellaneous Commercial Services | Director/Board Member | |
Magenta Medical Ltd.
 Magenta Medical Ltd. Medical SpecialtiesHealth Technology Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel. | Medical Specialties | Director/Board Member | |
| Galien Foundation | Director/Board Member | ||
| Motorola Automotive & Industrial Electronics Group | Corporate Officer/Principal | ||
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Messiah | College/University | Undergraduate Degree | |
| Wilmington University | College/University | Graduate Degree | |
| Eastern Michigan University | College/University | Masters Business Admin | |
| Indian Institute of Management & Commerce | College/University | Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Haverford College | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Drexel University | College/University | Undergraduate Degree | |
| Brandeis University | College/University | Undergraduate Degree | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| HCW BIOLOGICS INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 42 |
| Suisse | 4 |
| Israël | 3 |
| Canada | 2 |
| Inde | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 3 |
| Health Services | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 48 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 20 |
| Chairman | 16 |
| Undergraduate Degree | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Paul Truex | 17 |
| Seth Fischer | 17 |
| Richard Pasternak | 16 |
| Robert Wills | 13 |
| Michael Tomsicek | 12 |
| Lisa Giles | 12 |
| Debra Liebert | 12 |
| Joseph Oliveto | 7 |
| Amit Hasija | 7 |
| Lorenz Muller | 6 |
| Francis Plat | 6 |
| Guy Rousseau | 5 |
| Jeff Nelson | 4 |
| David Bharucha | 4 |
| Anita Holz | 4 |
- Bourse
- Insiders
- Kimberly Sheehan
- Connexions Sociétés
